Malignant acanthosis nigricans: an early diagnostic clue for gastric adenocarcinoma

Lee SS, Jung NJ, Im M, Lee Y, Seo YJ, Lee JH. Acral-type malignant acanthosis nigricans associated with gastric adenocarcinoma. Ann Dermatol. 2011;23:S208–10.

Kubicka-Wolkowska J, Debska-Szmich S, Lisik-Habib M, Noweta M, Potemski P. Malignant acanthosis nigricans associated with prostate cancer: a case report. BMC Urol. 2014;14:88.

McGinness J, Greer K. Malignant acanthosis nigricans and tripe palms associated with pancreatic adenocarcinoma. Cutis. 2006;78:37–40.

Hida Y, Kubo Y, Nishio Y, Murakami S, Fukumoto D, Sayama K, Hashimoto K, Arase S. Malignant acanthosis nigricans with enhanced expression of fibroblast growth factor receptor 3. Acta Derm Venereol. 2009;89:435–7.

Haase I, Hunzelmann N. Activation of epidermal growth factor receptor/ERK signaling correlates with suppressed differentiation in malignant acanthosis nigricans. J Invest Dermatol. 2002;118:891–3.

Ramos-E-Silva M, Carvalho JC, Carneiro SC. Cutaneous paraneoplasia. Clin Dermatol. 2011;29:541–7.

Kebria MM, Belinson J, Kim R, Mekhail TM. Malignant acanthosis nigricans, tripe palms and the sign of Leser-Tre’lat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literature. Gynecol Oncol. 2006;101:353–5.

Bazex A, Griffiths A. Acrokeratosis paraneoplastica—a new cutaneous marker of malignancy. Br J Dermatol. 1980;103:301–6.

Cabanillas M, Perez-Perez L, Sanchez-Aguilar D, Fernandez-Redondo V, Toribio J. Acrokeratosis paraneoplastica with bullous lesions associated with esophageal squamous cell carcinoma. Actas Dermosifiliogr. 2006;97:196–9.